ArriVent BioPharma (AVBP) Cash & Equivalents (2023 - 2026)
ArriVent BioPharma (AVBP) recorded Cash & Equivalents of $154.68 million in Q2 2026, up 37.2% from $112.77 million a year earlier and up 149.1% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Cash & Equivalents (2023 - 2026) Analysis & Trends
At the end of FY2025, ArriVent BioPharma reported Cash & Equivalents of $45.54 million, down 38.7% from FY2024.
- Across earlier years, Cash & Equivalents came in at $74.29 million in FY2024 (-50.6%) and $150.39 million in FY2023.
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents rose in two of the last seven quarters, with an average decline of 33.5%.
- Per Business Quant, the preceding three quarters came in at $62.1 million (Q1 2026), $45.54 million (Q4 2025) and $112.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 154.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.68 Mn |
| Mar 31, 2026 | 62.10 Mn |
| Dec 31, 2025 | 45.54 Mn |
| Sep 30, 2025 | 112.67 Mn |
| Jun 30, 2025 | 112.77 Mn |
| Mar 31, 2025 | 49.87 Mn |
| Dec 31, 2024 | 74.29 Mn |
| Sep 30, 2024 | 282.90 Mn |
| Jun 30, 2024 | 298.70 Mn |
| Mar 31, 2024 | 317.40 Mn |
| Dec 31, 2023 | 150.39 Mn |
API Access
ArriVent BioPharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();